Navigation Links
Pioneer(R) Surgical Technology, Inc. Closes $15 Million Series B Financing
Date:12/16/2008

MARQUETTE, Mich., Dec. 16 /PRNewswire/ -- Pioneer Surgical Technology, Inc., a leading innovator in the design and manufacture of spinal and orthopedic implants and instruments, today announced the closing of Series B financing totaling $15 million. Pioneer attracted new participation from InvestMichigan! Growth Capital Fund (IMGCF). Previous investors Pharos Capital Group, LLC; Highlander Partners, LP; Hopewell Ventures; and River Cities Capital Funds also participated in the round.

Pioneer's CEO and Chairman of the Board, Matthew N. Songer, MD, MBA says, "This capital will fund our FDA pivotal study for the NuBac nucleus replacement device, enabling us to bring this innovative P3(TM) technology to the U.S. market."

Pioneer is the first and only company to receive FDA approval to start the IDE pivotal study for lumbar nucleus replacement. The NuBac is a minimally-invasive device and is the first in a family of PEEK-on-PEEK articulating discs and implants developed by Pioneer.

IMGCF co-manager Charles Rothstein, of Beringea, Inc., commented, "With its focus on one of the largest, fastest growing and most profitable segments in the medical device industry, we feel confident Pioneer Surgical will be a valuable addition to the IMGCF portfolio."

The NuBac implant system is the only Nucleus Replacement device that utilizes an articulating inner ball and socket design that seeks to achieve load sharing and uniform stress distribution under various physiological loading conditions while minimizing extrusion risk. The NuBac implant is made of PEEK-OPTIMA(R) material which offers well established biocompatibility, biodurability, excellent wear resistance, and radiolucency.

San Francisco, California-based Thomas Weisel Partners served as sole financial advisor to Pioneer in connection with the Series B financing.

About Pioneer Surgical Technology

Pioneer Surgical Technology, Inc., headquartered in Marquette, Michigan, is a dynamic medical device firm with a full line of cutting-edge motion preservation devices, either available commercially in Europe or under clinical evaluation in the U.S. Pioneer's signature articulating P3(TM) Technology -- Pioneer PEEK-on-PEEK, in its NuBac(TM) disc arthroplasty system, BacJac(TM) interspinous decompression system, and NuNec(TM) artificial cervical disc, is the most technologically advanced in the industry. Currently, Pioneer offers a diverse portfolio of next generation spinal fusion devices. Pioneer's focus on innovation has resulted in over 100 U.S. and foreign patents with numerous patents pending. The company established a Biologics Division following two acquisitions in 2007. Pioneer Orthobiologics is developing a rich pipeline of products indicated for a variety of spinal and orthopaedic applications. Pioneer focuses on developing products which are easier and faster for the surgeon, cost effective for the health care system, and provide better patient outcomes. www.pioneersurgical.com

About InvestMichigan! Growth Capital Fund

The InvestMichigan! Fund is an economic development initiative created by Michigan Governor Jennifer Granholm. The fund is designed to retain and attract businesses to the State of Michigan and further develop the State's entrepreneurial ecosystem. The Growth Capital Program is co-managed by Beringea, a Michigan-based venture capital firm experienced in geographically targeted investment programs, and Credit Suisse's Customized Fund Investment Group, a highly-respected global network of funds and co-investments. info@beringea.com

About Pharos Capital Group, LLC

Based in Dallas and Nashville, Pharos Capital Group currently has approximately $600 million in capital under management. Pharos primarily invests $10 to $30 million in companies seeking later stage equity funding for internal growth, acquisitions, management buyouts or recapitalizations across industry sectors, with particular focus on health care, business services, and applied technology. www.pharosfunds.com

About Highlander Partners, LP

Highlander Partners is a private investment firm located in Dallas, Texas. The firm's core industries of interest and expertise are healthcare services, medical devices, specialized food ingredients, and building products and services. The principals of Highlander bring extensive operating and financial experience to bear in their investments. Highlander is also the majority general partner of Highlander Partners Healthcare Fund, a long/short healthcare services and medical device hedge fund. aguiva@highlander-partners.com

About Hopewell Ventures

Hopewell Ventures is a Chicago- and Peoria, IL-based venture capital and private equity firm providing growth and buyout capital to Midwestern businesses in a broad range of industries and stages of development. With more than a century of experience, Hopewell's team makes initial investments of $2 to $7 million. www.hopewellventures.com

About River Cities Capital Funds

River Cities Capital Funds provides growth equity to companies primarily in healthcare and information technology. With offices in Cincinnati and Raleigh and over $390 million in capital under management, River Cities actively seeks expansion stage companies throughout the Midwest and Southeast United States. www.rccf.com.


'/>"/>
SOURCE Pioneer Surgical Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Pioneer(R) Surgical Technologys NuBac(R) Nucleus Replacement Device Wins FDA Approval for IDE Pivotal Study
2. Pioneer(R) Surgical Technology Announces the Market Release of its Cross-Fuse(TM) Lateral Vertebral Body Replacement (VBR) System
3. Pioneer(R) Surgical Technology Introduces the BacJac(TM) Interspinous Decompression System to the European Spine Market
4. Pioneer(R) Surgical Technology, Inc. Continues to Prove Science Behind PEEK-on-PEEK(TM) Technology for Motion Preservation Devices
5. Aurora and Associated Surgical & Medical Specialists Announce Surgery Center Joint Venture
6. American College of Surgeons Issues New Health Care Reform Agenda, Emphasizes Need to Address Access, Surgical Workforce Shortage
7. Intelligent materials to revolutionize surgical implants
8. Levaquin is the Preferred Quinolone Among More Than Half of All General Medical-Surgical Hospitals in the United States
9. Molecular Breast Imaging Proves Cost-Effective for Presurgical Planning in Patients with Breast Cancer
10. Cardinal Health, SRI Surgical Sign Five-Year Agreement For Surgical Kits
11. New Surgical Approach Shows Promise in Treatment of Scoliosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... will be giving viewers the lowdown on sciatica in a new episode of ... that focuses on current events and innovation and investigates each subject in-depth with ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
(Date:10/12/2017)... LA (PRWEB) , ... October 12, 2017 , ... Planet ... in the U.S., announced today its plans to open a flagship location in Covington, ... occupy the former Rooms To Go store next to Office Depot in the Holiday ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) ... FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... Morris F. Collen, a pioneer in the field of medical informatics, this prestigious award ...
(Date:10/12/2017)... ... 2017 , ... Dr. Parsa Mohebi, the Los Angeles based ... the newly revamped Cosmetic Town journal section, featuring articles written by ... as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I enjoy ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
Breaking Medicine Technology: